Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘Mark Truty’

January 20, 2021 · Leave a Comment

PET/MRI biomarkers guide personalized treatment for patients with pancreatic cancer, study finds

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

By Ethan Grove Positron emission tomography (PET)/MRI has changed how Mayo Clinic specialists treat patients with pancreatic cancer. Mayo Clinic pioneered the use of PET/MRI to manage pancreatic cancer. Now a new study by Ananya Panda, M.B.B.S. (@AnanyaPanda15), and colleagues systematically evaluates the strengths of PET/MRI for pancreatic ductal adenocarcinoma. In less than five years, […]

View full entry Comment on this

Tags: Ajit Goenka, Ananya Panda, Bradley Kemp, chemotherapy, Eric Ehman, Garima Suman, Geoffrey Johnson, Jeff Fidler, Mark Truty, MRI, nuclear medicine, pancreatic cancer


May 1, 2019 · Leave a Comment

Research News Roundup-April 2019

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. Mayo Clinic, other experts call for urgent focus on brain disease that mimics Alzheimer’s In collaboration with the University of Kentucky, the […]

View full entry Comment on this

Tags: advance directive, Andrea Cheville, cancer, cardiology, clinical trials, HLHS, hypoplastic left heart syndrome, Mark Truty, pancreatic cancer, quality of life, radiation therapy, Research News Roundup


December 27, 2018 · Leave a Comment

Be the life [science] of the party

By Caitlin Doran Caitlin Doran (@caityrosey)

Looking for a scientific conversation starter for New Year’s Eve? Advancing the Science has you covered with this top-10 recap of our hottest medical research stories from 2018. With this list in your back pocket, you’ll never run out of interesting cocktail banter. And we guarantee you’ll wow your friends with your scientific smarts. #1  […]

View full entry Comment on this

Tags: celiac disease, end of life care, fetal surgery, gluten free, Imad Absah, liver disease, Mark Truty, maternal and fetal medicine, multiple sclerosis, nephrology, neuroimmunology, palliative care


October 3, 2018 · Leave a Comment

Mayo Clinic Awarded Nation’s First Hepatobiliary SPORE Grant

By Nicole Ferrara Nicole Ferrara (@nicoleferrara)

The National Cancer Institute (NCI) has awarded Mayo Clinic an $11.5 million grant to fund  a Specialized Program of Research Excellence (SPORE) in hepatobiliary cancer through August 2023. Headed by principal investigators Mark A. McNiven, Ph.D., and Lewis R. Roberts, M.B., Ch.B., Ph.D., the goal of the Mayo Clinic Hepatobiliary SPORE is to make discoveries […]

View full entry Comment on this

Tags: cancer, Chen Wang, Edward Leof, gastrointestinal cancer, Gregory Gores, John Copland III, Lewis Roberts, liver cancer, Mark McNiven, Mark Truty, Mayo Clinic Cancer Center, Michael Torbenson


July 2, 2018 · Leave a Comment

A revolution in pancreatic cancer treatment

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

Mark Truty, M.D., has dedicated his career to giving patients with pancreatic cancer more quality time with their loved ones. Much more time. The mission is personal for him. His own father, Kazimierz Truty, a Polish immigrant and mechanic at a meatpacking plant near Chicago, died 20 years ago from pancreatic cancer at age 58. “My […]

View full entry Comment on this

Tags: collaboration, Mark Truty, Mayo Clinic Cancer Center, pancreatic cancer, surgery


March 15, 2016 · Leave a Comment

New Treatment-Sequencing Based on Biomarker Elevation in Pancreatic Cancer

By Meghan Knoedler Meghan Knoedler (@meghanknoedler)

Pancreatic cancer is the fourth leading cause of death in men and women and is projected to increase to the second leading cause of death by 2020 if there are not significant treatment advances made. Our current understanding of pancreatic cancer suggests that it is a systemic disease in most patients, meaning, that by the time of […]

View full entry Comment on this

Tags: biomarkers, Center for the Science of Health Care Delivery, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, pancreatic cancer, surgery, surgical outcomes


November 10, 2015

Building the Evidence Base in Health Care Delivery — Underutilization of Inexpensive Test Could Have Dire Consequences

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

CA 19-9 tumor marker test especially important for early-stage patients, Mayo finds Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows. […]

View full entry

Tags: Carlos Puig, Center for the Science of Health Care Delivery, Christopher Shubert, David Nagorney, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, Michael Farnell, Michael Kendrick, pancreatic cancer, Rory Smoot, Ryan Groeschl


Contact Us · Privacy Policy